Cigna, Humana
CVS Health subsidiary Aetna, Cigna and Elevance Health ended commissions in Connecticut, Georgia, New York and Texas.
The flat-out denial comes after Cigna CEO David Cordani tried to throw cold water on persistent speculation of a Humana ...
Also, we still view pharmacy benefit management transparency as a key concern for both major political parties, but we expect potential legislation to be manageable for top-tier players like Cigna ...
Health insurance companies are counting on specialty pharmacy to invigorate their finances as other business lines face headwinds.
Cigna continues to sidestep significant pressures that have slammed its health insurance peers this year. The majority of the Connecticut-based payer’s business is with employer clients, which ...
Also: US Federal Trade Commission Sues CVS Health, Cigna, UnitedHealth’s Pharmacy Benefit Managers For Inflating Insulin Prices Last year, both companies faced challenges as they navigated ...
Medicaid and individual plan leader Centene also looks undervalued while CVS' problems in Medicare Advantage and PBM transparency concerns keep its shares deeply discounted. Cigna, Elevance ...
I've been a Cigna Global Health Insurance policyholder for seven years and had never filed a claim until recently. A few weeks ago, I had to undergo a surgical procedure. I first contacted Cigna ...
Baxter covers the Healthcare sector, focusing on stocks such as Humana, CVS Health, and Centene. Cigna has an analyst consensus of Strong Buy, with a price target consensus of $400.11. CI market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback